El-Opira

El-Opira is a private U.S. healthcare technology company developing advanced biomedical imaging tools for cancer diagnosis. Its work centers on photoacoustic imaging, optical coherence tomography, and associated software/image-analysis methods to improve visualization of tissue and tumor boundaries. The company has been described as targeting skin and brain cancers, with an early product focused on helping clinicians distinguish dangerous skin cancer from benign moles using software that works with existing medical equipment. Publicly available information suggests El-Opira remains an early-stage, privately held venture with accelerator backing rather than a commercial-stage biotech or pharma company. The company appears to sit at the intersection of medtech, diagnostics, and oncology imaging rather than therapeutic drug development.